169 related articles for article (PubMed ID: 37758006)
1. Poly (ADP-ribose) polymerase 1 and neurodegenerative diseases: Past, present, and future.
Hu ML; Pan YR; Yong YY; Liu Y; Yu L; Qin DL; Qiao G; Law BY; Wu JM; Zhou XG; Wu AG
Ageing Res Rev; 2023 Nov; 91():102078. PubMed ID: 37758006
[TBL] [Abstract][Full Text] [Related]
2. PARP1 inhibition alleviates injury in ARH3-deficient mice and human cells.
Mashimo M; Bu X; Aoyama K; Kato J; Ishiwata-Endo H; Stevens LA; Kasamatsu A; Wolfe LA; Toro C; Adams D; Markello T; Gahl WA; Moss J
JCI Insight; 2019 Feb; 4(4):. PubMed ID: 30830864
[TBL] [Abstract][Full Text] [Related]
3. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
Henning RJ; Bourgeois M; Harbison RD
Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
[TBL] [Abstract][Full Text] [Related]
4. Poly (ADP-ribose) polymerase-1 as a promising drug target for neurodegenerative diseases.
Thapa K; Khan H; Sharma U; Grewal AK; Singh TG
Life Sci; 2021 Feb; 267():118975. PubMed ID: 33387580
[TBL] [Abstract][Full Text] [Related]
5. PARP1 inhibition prevents oxidative stress in age-related hearing loss via PAR-Ca
Wan H; Chen H; Liu J; Yang B; Zhang Y; Bai Y; Chen X; Wang J; Liu T; Zhang Y; Hua Q
Free Radic Biol Med; 2024 Aug; 220():222-235. PubMed ID: 38735540
[TBL] [Abstract][Full Text] [Related]
6. Poly (ADP-Ribose) polymerase 1 and parthanatos in neurological diseases: From pathogenesis to therapeutic opportunities.
Xu X; Sun B; Zhao C
Neurobiol Dis; 2023 Oct; 187():106314. PubMed ID: 37783233
[TBL] [Abstract][Full Text] [Related]
7. MORC2 regulates DNA damage response through a PARP1-dependent pathway.
Zhang L; Li DQ
Nucleic Acids Res; 2019 Sep; 47(16):8502-8520. PubMed ID: 31616951
[TBL] [Abstract][Full Text] [Related]
8. Differential and Concordant Roles for Poly(ADP-Ribose) Polymerase 1 and Poly(ADP-Ribose) in Regulating WRN and RECQL5 Activities.
Khadka P; Hsu JK; Veith S; Tadokoro T; Shamanna RA; Mangerich A; Croteau DL; Bohr VA
Mol Cell Biol; 2015 Dec; 35(23):3974-89. PubMed ID: 26391948
[TBL] [Abstract][Full Text] [Related]
9. Medicinal chemistry approaches of poly ADP-Ribose polymerase 1 (PARP1) inhibitors as anticancer agents - A recent update.
Jain PG; Patel BD
Eur J Med Chem; 2019 Mar; 165():198-215. PubMed ID: 30684797
[TBL] [Abstract][Full Text] [Related]
10. PARP1: Structural insights and pharmacological targets for inhibition.
Spiegel JO; Van Houten B; Durrant JD
DNA Repair (Amst); 2021 Jul; 103():103125. PubMed ID: 33940558
[TBL] [Abstract][Full Text] [Related]
11. Clinical PARP inhibitors do not abrogate PARP1 exchange at DNA damage sites in vivo.
Shao Z; Lee BJ; Rouleau-Turcotte É; Langelier MF; Lin X; Estes VM; Pascal JM; Zha S
Nucleic Acids Res; 2020 Sep; 48(17):9694-9709. PubMed ID: 32890402
[TBL] [Abstract][Full Text] [Related]
12. Poly(ADP-ribose) Polymerase 1 Mediates Rab5 Inactivation after DNA Damage.
Mashimo M; Morozumi A; Nobeyama A; Kanzaki M; Negi S; Kato J; Moss J; Nomura A; Fujii T
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887176
[TBL] [Abstract][Full Text] [Related]
13. Captured snapshots of PARP1 in the active state reveal the mechanics of PARP1 allostery.
Rouleau-Turcotte É; Krastev DB; Pettitt SJ; Lord CJ; Pascal JM
Mol Cell; 2022 Aug; 82(16):2939-2951.e5. PubMed ID: 35793673
[TBL] [Abstract][Full Text] [Related]
14. [PARP1 inhibitors: contemporary attempts at their use in anticancer therapy and future perspective].
Wiśnik E; Ryksa M; Koter-Michalak M
Postepy Hig Med Dosw (Online); 2016 Apr; 70():280-94. PubMed ID: 27117104
[TBL] [Abstract][Full Text] [Related]
15. The role of PARP1 in neurodegenerative diseases and aging.
Mao K; Zhang G
FEBS J; 2022 Apr; 289(8):2013-2024. PubMed ID: 33460497
[TBL] [Abstract][Full Text] [Related]
16. Targeting the DNA Damage Response for Cancer Therapy.
Wang R; Sun Y; Li C; Xue Y; Ba X
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958890
[TBL] [Abstract][Full Text] [Related]
17. The activity and inhibition of poly(ADP-ribose) polymerase-1 in equine peripheral blood mononuclear cells in vitro.
Douglas HF; Southwood LL; Meyer-Ficca ML; Hart SK; Meyer RG
J Vet Emerg Crit Care (San Antonio); 2015; 25(4):528-37. PubMed ID: 26040949
[TBL] [Abstract][Full Text] [Related]
18. [Poly(ADP-Ribose) Polymerases 1 and 2: Classical Functions and Interaction with New Histone Poly(ADP-Ribosyl)ation Factor HPF1].
Kurgina TA; Lavrik OI
Mol Biol (Mosk); 2023; 57(2):254-268. PubMed ID: 37000654
[TBL] [Abstract][Full Text] [Related]
19. Phosphatase 1 Nuclear Targeting Subunit Mediates Recruitment and Function of Poly (ADP-Ribose) Polymerase 1 in DNA Repair.
Wang F; Zhu S; Fisher LA; Wang L; Eurek NJ; Wahl JK; Lan L; Peng A
Cancer Res; 2019 May; 79(10):2526-2535. PubMed ID: 30733193
[TBL] [Abstract][Full Text] [Related]
20. Chaperone-mediated autophagy attenuates H
Zhang D; Lai W; Liu Y; Wan R; Shen Y
Cell Biol Int; 2022 Nov; 46(11):1915-1926. PubMed ID: 35924992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
